Skip to Content

BMS 6077 (Metaglip 2.5 mg / 500 mg)

Generic Name: glipizide/metformin

Pill with imprint BMS 6077 is White, Elliptical / Oval and has been identified as Metaglip 2.5 mg / 500 mg. It is supplied by Bristol-Myers Squibb.

Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 2.5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 6077

Metaglip

Generic Name
glipizide/metformin
Imprint
BMS 6077
Strength
2.5 mg / 500 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
National Drug Code (NDC)
00087-6077

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.